source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

EVENT PREVIEW: CPhI North America opens next week!

CPhI North America, “the only pharmaceutical industry event for the North American supply chain”, takes place from Tuesday, April 30 to Thursday, May 2 this year at McCormick Place, Chicago, Illinois, USA and will attract more than 6500 pharmaceutical industry professionals as attendees who will gather to network, source products and services, and learn about new technologies and industry developments. Eighty per cent of attendees have a role in the purchasing cycle, while sixty-eight per cent of attendees in the past have said that they were likely to do business with one or more exhibiting companies. Forty-eight per cent of attendees were new to CPhI events.

The CPhI North America Bond Meeting Service is an exclusive, free-to-use, networking service that allows registered attendees and exhibitors to search, connect and book meetings with key contacts at the show, helping attendees to utilise their time at the event.

Keynote address by Senator Jeff Flake

One of the main highlights at this year’s CPhI North America will be the April 30 keynotepresentation in which Senator Jeff Flake will give his opinions on pharma manufacturing, health care innovation, and the direction of health care as he sees it under the current US governmental structure, as well as scenarios beyond 2020. Senator Flake has nearly two decades of experience on Capitol Hill in both the Senate and the House of Representatives and is renowned for his principled stands on spending and free trade, and his negotiations and bipartisanship on complicated issues such as immigration.

CPhI North America Conference

At the CPhI North America Conference, pharma leaders gather annually to discuss pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small- and large-molecule finished drugs as well as advances in biomanufacturing. This year’s conference tracks re as follows:

Drug development, featuring:

Building a Better Drug: Strategies to Enhance Patient Drug Regimen Adherence

Development & Manufacturing Considerations of High Potent Drug Products – a CDMO’s Perspective

Outsourcing of NDA Approvals and CMO Performance in 2018 and Future Outlook

Chemical Facilities Outreach Exchange

Miniaturization Pharmaceutical Technology (MPTech®) - An API Manufacturing Process to Increase the Operational Efficiency and Its Impact and Benefits on Patients

High Potency API (HPAPI) Best Practices - Controlling Quality

Formulation Trends Spotlight: Semi-Solid, Topical and Transdermal

Quality by Design: Methods for Optimizing Spray-Dried Dispersions for Bioavailability Enhancement

Is a geographically integrated CMC supply chain the next evolution of the CDMO model?

Continuous, on-demand dehydration of solvents in flow chemistry manufacturing processes

Drug manufacturing, featuring:

API Part I - Advances in API Synthesis and Manufacturing

API Part II - Advances in API Synthesis and Manufacturing

When Science and Politics Collide: A Political Forecast Into 2019 and Issues That Will Impact Chemical Processing

Quality Risk Assessment in Pharmaceutical Industry

Challenges in Extractables and Leachables Studies of Plastic Process Materials

AI, IoT and the Road to Pharma 4.0

Pharma’s Problem with Data integrity 

Extrusion Applications in Manufacturing Pharmaceutical Oral Drug Products

Innovation without Imitation: Utilizing U.S. FDA Drug Master Files

The System Development Lifecycle (SDLC) and Computer System Validation (CSV) in Drug Manufacturing

The Critical Approach to the Design of a HPAPI Suite in a Multi-use Facility 

Bio-Processing Track

Upstream processing: A new approach for scalability and transfer

Filling The Gap in Skilled Workforce Shortage in Biomanufacturing

The CPhI North America Exhibition

The CPhI North America Exhibition comprises a number of Zones as follows:

The CPhI Zone in which products and services include:

APIs & Generic APIs:


Amino Acids





Hormones & Synthetic Substances





Sera and Vaccines

Custom Manufacturing:

API Contract Manufacturing

Custom Manufacturing (general category)

Custom Manufacturing of Dosage Form Drugs

Custom Manufacturing/Exclusive Synthesis of Fine Chemicals

Exclusive synthesis of API’s, Immunochemistry, Purification and Separation Techniques


Antimicrobial Preservatives



Coating Agents

Colour and Dispersions

Drug Delivery Systems

Drug Formulation

Emulsifying/Solubilising Agents

Flavours and Perfumes


Ointments Bases


Suppository Bases

Suspending/Viscosity Increasing Agents

Sweetening Agents

Tablet Filler-Binders

Natural extracts:

Animal extracts

Dietary fibre

Dietary supplement ingredients

Food additives

Functional food ingredients

Nutraceutical and cosmeceutical ingredients

Plant extracts

The InformEx Zone at CPhI North America

InformEx, the speciality chemical focused zone at CPhI North America, has a 30-year history as the premier global source for developing valuable scientific partnerships. The integration with CPhI North America delivers an audience of sourcing and procurement professionals from big pharma and beyond. The global speciality chemicals market is estimated to reach $47 billion by 2020 while the global pharmacetical market will reach nearly $1.43 trillion by 2020. The US share of the global pharmaceuticals market is projected to increase to 41% by 2020.

The Finished Drug Formulations (FDF) Zone at CPhI North America

Manufacturing of finished dosage formulations is expected to grow at an average CAGR of 8.7% by 2020 and North America forms a $50 billion formulations market, equating to a 31% market share. Increased demand for generics is expected to continue to rise given its high market penetration and increased global demand for affordable prescription and OTC drugs are forcing the industry to manufacture high levels of safe, high-quality, and cost-effective drugs efficiently. Products and services in the FDF Zone include:


Antimicrobial Preservatives



Coating Agents

Colour and Dispersions

Drug Formulation (general category)

Emulsifying/Solubilising Agents

Flavours and Perfumes





Suppository Bases

Suspending/Viscosity Increasing Agents

Sweetening Agents

Tablet Filler-Binders

Finished dosage formulations:





Gel caps







Soft tabs




Transdermal patches

The other zones at CPhI North America are the bioLIVE Zone, uniting the small- and large-molecule markets and bringing together buyers and sellers in biopharma processing and manufacturing; the InnoPack packaging zone, featuring products in sustainable, patient-centric packaging; and the P-MEC machinery zone, featuring transformative trends in machinery and equipment.

Show Floor Hours

Tuesday, April 30, 2019 10:00am to 5:00pm

Wednesday, May 1, 2019 10:00am to 5:00pm

Thursday, May 2, 2019 10:00am to 3:00pm


For further information visit 

Last modified onWednesday, 24 April 2019 11:03

Latest from Tom Mulligan